Literature DB >> 2185781

Antiphospholipid antibodies: more than just a disease marker?

C Mackworth-Young1.   

Abstract

Considerable interest has arisen over the past few years in a clinical syndrome characterized by a tendency to arterial or venous thrombosis, and the presence in the serum of antibodies to anionic phospholipids. In this article, Charles Mackworth-Young reviews the clinical features of this so-called 'anti-phospholipid syndrome', the characteristics of the anti-phospholipid response and the evidence for a possible role for these antibodies in pathogenesis.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2185781     DOI： 10.1016/0167-5699(90)90020-a

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  21 in total

Review 1.  Antiphospholipid antibodies and cardiovascular disease.

Authors:  H L Beynon; M J Walport
Journal:  Br Heart J       Date:  1992-04

2.  Identification of antiphospholipid antibodies in systemic lupus erythematosus on thin layer chromatography and immunostaining.

Authors:  I Katayama; Y Hamada; K Otoyama; S Nishiyama; K Nishioka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 3.  Anti-beta 2-glycoprotein I antibodies and thrombosis.

Authors:  J P Viard; Z Amoura; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 4.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

5.  Anti-cardiolipin antibodies in patients with inflammatory bowel disease.

Authors:  B W Aichbichler; W Petritsch; G A Reicht; H H Wenzl; A J Eherer; T A Hinterleitner; P Auer-Grumbach; G J Krejs
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 6.  Primary antiphospholipid antibody syndrome and cerebral ischemia: report on acute intervention in two cases and literature review with emphasis on therapeutic options.

Authors:  S Braune; R Siekmann; P Vaith; C H Lücking
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

7.  A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.

Authors:  T Olee; S S Pierangeli; H H Handley; D T Le; X Wei; C J Lai; J En; W Novotny; E N Harris; V L Woods; P P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

8.  High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria.

Authors:  C A Facer; G Agiostratidou
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 9.  Diversity and origin of rheumatologic autoantibodies.

Authors:  M J Fritzler; M Salazar
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice.

Authors:  P Fishman; R Bakimer; M Blank; D Sredni; M Djaldetti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.